These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
234 related items for PubMed ID: 6238931
1. In-vitro activity of enoxacin, ofloxacin, norfloxacin and nalidixic acid. Bauernfeind A, Ullmann U. J Antimicrob Chemother; 1984 Sep; 14 Suppl C():33-8. PubMed ID: 6238931 [Abstract] [Full Text] [Related]
2. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates. Bassey CM, Baltch AL, Smith RP. J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401 [Abstract] [Full Text] [Related]
3. [Sensitivity of obligate anaerobes to ofloxacin, pefloxacin, enoxacin and norfloxacin]. Dubreuil L, Devos J, Romond C, Bryskier A. Pathol Biol (Paris); 1985 May; 33(5):421-5. PubMed ID: 3162143 [Abstract] [Full Text] [Related]
4. The comparative in-vitro activity of norfloxacin, ciprofloxacin, enoxacin and nalidixic acid against 423 strains of gram-negative rods and staphylococci isolated from infected hospitalised patients. Guimaraes MA, Noone P. J Antimicrob Chemother; 1986 Jan; 17(1):63-7. PubMed ID: 2936708 [Abstract] [Full Text] [Related]
5. The in-vitro activity of EN 272, a quinolone-7-carboxylic acid, in comparison with other quinolones. Neu HC. J Antimicrob Chemother; 1985 Jul; 16(1):43-8. PubMed ID: 3862659 [Abstract] [Full Text] [Related]
6. The comparative in-vitro activity of eight newer quinolones and nalidixic acid. King A, Phillips I. J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100 [Abstract] [Full Text] [Related]
11. Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates. Arpi M, Gahrn-Hansen B, Søgaard P, Bentzon MW. Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):141-6. PubMed ID: 3473910 [Abstract] [Full Text] [Related]
12. In vitro activity of enoxacin compared with norfloxacin and amikacin. van der Auwera P, de Moor G, Lacroix G, Mambour A, Rossion N, Schuyteneer F. Eur J Clin Microbiol; 1985 Feb; 4(1):55-8. PubMed ID: 3157568 [Abstract] [Full Text] [Related]
16. In vitro evaluation of A-56619 and A-56620, two new quinolones. Barry AL, Thornsberry C, Jones RN. Antimicrob Agents Chemother; 1986 Jan; 29(1):40-3. PubMed ID: 2942099 [Abstract] [Full Text] [Related]
17. [In vitro activity of new quinolones against nonfermenters and references to sensitivity tests]. Grimm H. Infection; 1986 Jan; 14 Suppl 3():S191-5. PubMed ID: 3093387 [Abstract] [Full Text] [Related]